185 related articles for article (PubMed ID: 29463235)
21. Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Murtola TJ; Vihervuori VJ; Lahtela J; Talala K; Taari K; Tammela TL; Auvinen A
Br J Cancer; 2018 May; 118(9):1248-1254. PubMed ID: 29563633
[TBL] [Abstract][Full Text] [Related]
22. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
[TBL] [Abstract][Full Text] [Related]
23. High levels of both serum gamma-glutamyl transferase and alkaline phosphatase are independent preictors of mortality in patients with stage 4-5 chronic kidney disease.
Caravaca-Fontán F; Azevedo L; Bayo MÁ; Gonzales-Candia B; Luna E; Caravaca F
Nefrologia; 2017; 37(3):267-275. PubMed ID: 28648203
[TBL] [Abstract][Full Text] [Related]
24. Elevated fasting glucose and albuminuria may be a marker for all-cause mortality in Indigenous adults in North Queensland - a follow up study, 1998-2006.
Li M; McDermott R
J Diabetes Complications; 2017 Apr; 31(4):708-714. PubMed ID: 28087205
[TBL] [Abstract][Full Text] [Related]
25. γ-Glutamyltransferase and cancer risk: The Korean cancer prevention study.
Mok Y; Son DK; Yun YD; Jee SH; Samet JM
Int J Cancer; 2016 Jan; 138(2):311-9. PubMed ID: 26111622
[TBL] [Abstract][Full Text] [Related]
26. Differences among men on active surveillance for very low-risk prostate cancer detected through population-based versus opportunistic prostate-specific antigen-screening.
Randazzo M; Beatrice J; Huber A; Grobholz R; Manka L; Recker F; Kwiatkowski M
Urol Int; 2015; 94(3):330-6. PubMed ID: 25633871
[TBL] [Abstract][Full Text] [Related]
27. Low fructosamine and mortality - A long term follow-up of 215,011 non-diabetic subjects in the Swedish AMORIS study.
Malmström H; Wändell PE; Holzmann MJ; Ärnlöv J; Jungner I; Hammar N; Walldius G; Carlsson AC
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1120-1128. PubMed ID: 27751668
[TBL] [Abstract][Full Text] [Related]
28. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
29. Alanine aminotransferase and gamma-glutamyl transferase have different dose-response relationships with risk of mortality by age.
Oh CM; Won YJ; Cho H; Lee JK; Park BY; Jun JK; Koh DH; Ki M; Jung KW; Oh IH
Liver Int; 2016 Jan; 36(1):126-35. PubMed ID: 26036985
[TBL] [Abstract][Full Text] [Related]
30. Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study.
Crawley D; Garmo H; Rudman S; Stattin P; Zethelius B; Armes J; Holmberg L; Adolfsson J; Van Hemelrijck M
BMJ Open; 2018 Mar; 8(3):e020787. PubMed ID: 29549214
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose.
Van Hemelrijck M; Garmo H; Holmberg L; Walldius G; Jungner I; Hammar N; Lambe M
Cancer; 2011 May; 117(10):2086-95. PubMed ID: 21523720
[TBL] [Abstract][Full Text] [Related]
32. Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.
Wallerstedt A; Strom P; Gronberg H; Nordstrom T; Eklund M
J Natl Cancer Inst; 2018 Nov; 110(11):1216-1221. PubMed ID: 29548030
[TBL] [Abstract][Full Text] [Related]
33. Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study.
Melvin JC; Seth D; Holmberg L; Garmo H; Hammar N; Jungner I; Walldius G; Lambe M; Wigertz A; Van Hemelrijck M
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1381-4. PubMed ID: 22593241
[TBL] [Abstract][Full Text] [Related]
34. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer.
Crawley D; Garmo H; Rudman S; Stattin P; Häggström C; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
Int J Cancer; 2016 Dec; 139(12):2698-2704. PubMed ID: 27557616
[TBL] [Abstract][Full Text] [Related]
35. Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer.
O'Farrell S; Garmo H; Holmberg L; Adolfsson J; Stattin P; Van Hemelrijck M
J Clin Oncol; 2015 Apr; 33(11):1243-51. PubMed ID: 25732167
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer outcomes for men who present with symptoms at diagnosis.
Beckmann KR; O'Callaghan ME; Ruseckaite R; Kinnear N; Miller C; Evans S; Roder DM; Moretti K;
BJU Int; 2017 Jun; 119(6):862-871. PubMed ID: 27489140
[TBL] [Abstract][Full Text] [Related]
37. Gamma-glutamyl transferase predicts future stroke: A Korean nationwide study.
Yang W; Kim CK; Kim DY; Jeong HG; Lee SH
Ann Neurol; 2018 Feb; 83(2):375-386. PubMed ID: 29372929
[TBL] [Abstract][Full Text] [Related]
38. Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality.
Ulmer H; Kelleher C; Diem G; Concin H
J Womens Health (Larchmt); 2004; 13(1):41-53. PubMed ID: 15006277
[TBL] [Abstract][Full Text] [Related]
39. Increased γ-glutamyl transferase levels predict early mortality in patients with acute pulmonary embolism.
Zorlu A; Yucel H; Bektasoglu G; Turkdogan KA; Eryigit U; Sarikaya S; Ege MR; Tandogan I; Yilmaz MB
Am J Emerg Med; 2012 Jul; 30(6):908-15. PubMed ID: 22386346
[TBL] [Abstract][Full Text] [Related]
40. γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study.
Kunutsor SK; Khan H; Laukkanen JA
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
